FDA.reportPublic FDA data

Acthar Gel 40 UNT in 0.5 ML Prefilled SelfJect Injector

RxCUI
2685299
RxNorm name
Acthar Gel 40 UNT in 0.5 ML Prefilled SelfJect Injector
Display name
Acthar Gel 40 UNT in 0.5 ML Prefilled SelfJect Injector
Full name
Acthar Gel 40 UNT in 0.5 ML Prefilled SelfJect Injector
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:39:05

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
7b48ddec-e815-45f4-9ca0-5c0daaf56f30Acthar Gel 40 UNT in 0.5 ML Prefilled SelfJect Injector [PSN] · 0.5 ML corticotropin 80 UNT/ML Prefilled Syringe [Acthar] [SBD] · 0.5 ML Acthar 80 UNT/ML Prefilled Syringe [SY] · Acthar Gel 40 UNT per 0.5 ML Prefilled SelfJect Injector [SY]428These highlights do not include all the information needed to use ACTHAR ® GEL safely and effectively. See full prescribing information for ACTHAR GEL. ACTHAR GEL (repository corticotropin injection), for intramuscular or subcutaneous use Initial U.S. Approval: 195220251205